Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04206501 · ClinicalTrials.gov registry record · NA
OptiVol for Precision Medical Management of Heart Failure
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04206501 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 7 participants.
The verdict
NCT04206501, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This clinical study is designed to show that a multidisciplinary team following a pre-specified standard of care medication decision model based on data from an implanted cardioverter device will increase the rate of change in Guideline Directed Medical Therapy (GDMT) in the intervention group compared to the conventional group in patients with ischemic and non-ischemic cardiomyopathies.
Interventions
- DEVICE Medtronic ICD with Opti Vol-Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-02-05 |
| Est. Completion | 2022-11-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04206501
The ClinicalTrials.gov registry entry for NCT04206501 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic ICD with Opti Vol-Monitor is the first listed.
NCT04206501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04206501 about?
NCT04206501 is a clinical study titled "OptiVol for Precision Medical Management of Heart Failure". This clinical study is designed to show that a multidisciplinary team following a pre-specified standard of care medication decision model based on data from an implanted cardioverter device will increase the rate of change in Guideline Directed Medical Therapy (GDMT) in the intervention group compa...
What is the current status of trial NCT04206501?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2020-02-05. Estimated completion is 2022-11-20.
What interventions are being tested in trial NCT04206501?
The interventions under investigation include: Medtronic ICD with Opti Vol-Monitor (DEVICE).
Who is sponsoring clinical trial NCT04206501?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.